[go: up one dir, main page]

Tovey, 2018 - Google Patents

Pharmaceutical formulation: the science and technology of dosage forms

Tovey, 2018

Document ID
9326945944739476888
Author
Tovey G
Publication year

External Links

Snippet

Formulation is a key step in the drug design process, where the active drug is combined with other substances that maximise the therapeutic potential, safety and stability of the final medicinal product. Modern formulation science deals with biologics as well as small …
Continue reading at books.google.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/103—Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/007—Marking tablets or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use

Similar Documents

Publication Publication Date Title
Tovey Pharmaceutical formulation: the science and technology of dosage forms
Boniatti et al. Direct powder extrusion 3d printing of praziquantel to overcome neglected disease formulation challenges in paediatric populations
Auriemma et al. Additive manufacturing strategies for personalized drug delivery systems and medical devices: fused filament fabrication and semi solid extrusion
Serrano et al. 3D printing technologies in personalized medicine, nanomedicines, and biopharmaceuticals
Karalia et al. 3D-Printed oral dosage forms: Mechanical properties, computational approaches and applications
Bácskay et al. The evolution of the 3D-printed drug delivery systems: a review
Rodríguez-Pombo et al. Innovations in chewable formulations: the novelty and applications of 3D printing in drug product design
Araújo et al. The digital pharmacies era: How 3D printing technology using fused deposition modeling can become a reality
Tan et al. Advanced pharmaceutical applications of hot-melt extrusion coupled with fused deposition modelling (FDM) 3D printing for personalised drug delivery
Trofimiuk et al. How to modify drug release in paediatric dosage forms? Novel technologies and modern approaches with regard to children’s population
Hu et al. Formulation and characterisation of carbamazepine orodispersible 3D-printed mini-tablets for paediatric use
Gaikwad et al. Review on Tablet in Tablet techniques
Al-Khattawi et al. Challenges and emerging solutions in the development of compressed orally disintegrating tablets
Ruiz-Caro et al. Characterization and dissolution study of chitosan freeze-dried systems for drug controlled release
Seoane-Viaño et al. 3D printing of pharmaceutical products
Brunaugh et al. Essential pharmaceutics
Ianno et al. Pediatric formulations developed by extrusion-based 3D printing: from past discoveries to future prospects
Elezaj et al. Pharmaceutical development of film-coated mini-tablets with losartan potassium for epidermolysis bullosa
Woerdenbag et al. Performance of tablet splitters, crushers, and grinders in relation to personalised medication with tablets
Gupta et al. A comprehensive review of patented technologies to fabricate orodispersible films: proof of patent analysis (2000–2020)
Sjöholm et al. Compounding tailored veterinary chewable tablets close to the point-of-care by means of 3D printing
van Kampen et al. The quest for child-friendly carrier materials used in the 3D semi-solid extrusion printing of medicines
Xue et al. A bibliometric analysis of 3D printing in personalized medicine research from 2012 to 2022
Parramon-Teixido et al. A framework for conducting clinical trials involving 3D printing of medicines at the point-of-care
Yasin et al. Fabrication of polypill pharmaceutical dosage forms using fused deposition modeling 3D printing: a systematic review